Trial Profile
The Pharmacokinetics Of Pregabalin Controlled Release Formulation In Fed State Compared To The Controlled Release And Immediate Release Formulations In The Fasted State.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 30 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2011 New trial record